Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
21.08
+0.42 (2.03%)
Aug 5, 2026, 4:00 PM EDT - Market closed
Sabra Health Care REIT Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 231.58 | 71.54 | 60.47 | 41.29 | 49.31 | 4.14 |
Cash & Short-Term Investments | 231.58 | 71.54 | 60.47 | 41.29 | 49.31 | 4.14 |
Cash Growth | 143.32% | 18.31% | 46.47% | -16.27% | 1092.17% | -69.95% |
Accounts Receivable | - | - | - | - | - | 1.59 |
Other Receivables | - | - | - | - | - | 4.34 |
Total Trade Receivables | - | - | - | - | - | 5.93 |
Restricted Cash | 6.76 | 6.6 | 5.87 | 5.43 | 4.62 | 12.41 |
Other Current Assets | 130.1 | 111.29 | 131.76 | 133.81 | 147.91 | 1.46 |
Total Current Assets | 368.44 | 189.43 | 198.09 | 180.53 | 201.84 | 23.95 |
Net Property, Plant & Equipment | 4,832 | 4,686 | 4,514 | 4,617 | 4,959 | 379.26 |
Other Intangible Assets | 82.95 | 65.32 | 27.46 | 30.9 | 40.13 | - |
Long-Term Investments | 228.97 | 552.27 | 564.39 | 557.47 | 546.36 | - |
Other Long-Term Assets | - | - | - | - | - | 64.56 |
Total Assets | 5,513 | 5,493 | 5,304 | 5,386 | 5,748 | 467.76 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 114.95 | 119.33 | 117.9 | 136.98 | 142.26 | 12.06 |
Accrued Expenses | - | - | - | - | - | 21.02 |
Unearned Revenue | - | - | - | - | - | 8.64 |
Total Current Liabilities | 114.95 | 119.33 | 117.9 | 136.98 | 142.26 | 41.71 |
Long-Term Debt | 2,266 | 2,268 | 2,266 | 2,272 | 2,261 | 757.1 |
Other Long-Term Liabilities | 19.05 | 21.38 | 26.85 | 32.53 | 42.24 | 23.35 |
Total Long-Term Liabilities | 2,286 | 2,289 | 2,293 | 2,305 | 2,303 | 780.45 |
Total Liabilities | 2,760 | 2,670 | 2,562 | 2,584 | 2,691 | 822.16 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2.56 | 2.52 | 2.38 | 2.31 | 2.31 | - |
Additional Paid-in Capital | 4,894 | 4,836 | 4,593 | 4,495 | 4,487 | - |
Accumulated Other Comprehensive Income | 6.1 | -3.57 | 20.94 | 23.75 | 19.06 | - |
Retained Earnings | -2,152 | -2,013 | -1,875 | -1,718 | -1,452 | - |
Total Common Shareholders' Equity | 2,751 | 2,822 | 2,741 | 2,803 | 3,056 | -354.4 |
Minority Interest | 1.72 | 1.95 | - | - | - | - |
Shareholders' Equity | 2,752 | 2,824 | 2,741 | 2,803 | 3,056 | -354.4 |
Total Liabilities & Equity | 5,513 | 5,493 | 5,304 | 5,386 | 5,748 | 467.76 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2,266 | 2,268 | 2,266 | 2,272 | 2,261 | 757.1 |
Net Cash (Debt) | -2,035 | -2,197 | -2,205 | -2,231 | -2,211 | -752.97 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -8.10 | -8.98 | -9.34 | -9.58 | -9.57 | -3.44 |
Book Value | 2,751 | 2,822 | 2,741 | 2,803 | 3,056 | -354.4 |
Book Value Per Share | 10.95 | 11.54 | 11.61 | 12.04 | 13.23 | -1.62 |
Tangible Book Value | 2,668 | 2,757 | 2,714 | 2,772 | 3,016 | -354.4 |
Tangible Book Value Per Share | 10.62 | 11.27 | 11.50 | 11.91 | 13.06 | -1.62 |